Fig. 3: Multivariate analysis of clinical signs and symptoms to evaluate the impact on thrombotic risk in the overall patient cohort. | Leukemia

Fig. 3: Multivariate analysis of clinical signs and symptoms to evaluate the impact on thrombotic risk in the overall patient cohort.

From: Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea

Fig. 3

CVRFs cardiovascular risk factors, HU hydroxyurea, HR hazard ratio, CI confidence interval. Red dots identify variable statistically significantly associated with a higher probability of thrombosis during hydroxyurea in both multivariate and univariate analysis; Yellow dots identify variable statistically significantly associated with a higher probability of thrombosis during hydroxyurea only in univariate analysis.

Back to article page